HealthStream (NasdaqGS:HSTM) Q4 2025 Earnings call February 24, 2026 09:00 AM ET Company ParticipantsMollie Condra - Head of Investor Relations and CommunicationsRichard Close - Managing Director of Digital and Tech-Enabled Health Equity ResearchRobert A. Frist Jr. - CEO and ChairmanRyan Daniels - Partner and Group Head of Healthcare Technology and ServicesScotty Roberts - CFO and SVP of Finance and AccountingConference Call ParticipantsConstantine Davides - Managing Director and Senior Equity AnalystMatthe ...

HealthStream (NasdaqGS:HSTM) Q4 2025 Earnings call February 24, 2026 09:00 AM ET Company ParticipantsMollie Condra - Head of Investor Relations and CommunicationsRichard Close - Managing Director of Digital and Tech-Enabled Health Equity ResearchRobert A. Frist Jr. - CEO and ChairmanRyan Daniels - Partner and Group Head of Healthcare Technology and ServicesScotty Roberts - CFO and SVP of Finance and AccountingConference Call ParticipantsConstantine Davides - Managing Director and Senior Equity AnalystMatthe ...

HealthStream (NasdaqGS:HSTM) Q4 2025 Earnings call February 24, 2026 09:00 AM ET Speaker3Good morning, and welcome to HealthStream's fourth quarter and full year 2025 earnings conference call. At this time, I would like to inform you that the conference is being recorded and that all participants are in listen-only mode. At the request of the company, we will open the conference up for questions and answers after the presentation. I would now like to turn the conference over to Mollie Condra, Head of Invest ...

Management attributes their resilient market position to serving as a 'system of record' for healthcare organizations, which they believe makes their data foundational for future AI implementations rather than replaceable by them. Performance was driven by strong adoption of the Competency Suite and flagship products like CredentialStream and ShiftWizard, which are successfully replacing legacy and horizontal competitors. The company is pivoting toward an 'ecosystem' strategy, using the hStream platfo ...

Financial Data and Key Metrics Changes - The company achieved record quarterly revenues of $76.5 million, up 4.6% from the same quarter last year [10] - Operating income increased by 16.5% to $7.6 million, while net income rose 6.3% to $6.1 million [10] - Adjusted EBITDA reached a new high of $19.1 million, up 7.9%, with an Adjusted EBITDA margin of 25% compared to 24.2% last year [13][10] - Earnings per share (EPS) increased to $0.20 from $0.19 [10] Business Line Data and Key Metrics Changes - Subscription revenues grew by $4 million, or 5.7%, while professional service revenues declined by $0.6 million, or 18.6% [10] - CredentialStream revenue grew by 23%, ShiftWizard by 29%, and CompetencySuite by 18% [11] - Revenues from legacy applications declined by $1.7 million compared to last year, but the core business grew by 8% when excluding legacy impacts [11] Market Data and Key Metrics Changes - Remaining performance obligations were $621 million, up from $549 million year-over-year, with expectations of converting approximately 39% to revenue over the next 12 months [11] - The company reported a strong cash balance of $92.6 million at the end of Q3 2025, with no interest-bearing debt [9] Company Strategy and Development Direction - The recent acquisition of Versus 12 enhances the company's entry into the payer and health plan market, which is expected to grow significantly [5][6] - The company is focusing on developing its career networks, which provide value directly to healthcare professionals, alongside its enterprise application suites [19][20] - HealthStream aims to connect its career networks with enterprise solutions through its HStream technology platform, enhancing the value of both [20][25] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the growth potential in the payer market and the synergies expected from the Versus 12 acquisition [34][35] - The company updated its financial guidance for the full year 2025, expecting consolidated revenues between $299.5 million and $301.5 million [17] - Management acknowledged challenges from declining legacy software revenues, estimating a $3 million drop in Q4, which could offset new growth [72] Other Important Information - The company maintains a disciplined approach to capital allocation, prioritizing organic investments, acquisitions, and returning profits to shareholders [14][15] - A quarterly cash dividend of $0.31 per share was declared, to be paid on November 28 [18] Q&A Session Summary Question: Can you provide more details on the Versus 12 acquisition and its market? - Management indicated that the payer market requires distinct solutions and that the acquisition brings valuable expertise and technology to better meet customer needs [34][35] Question: What are the expectations for Adjusted EBITDA margins in the future? - Management noted that the shift towards owning more content and higher-margin products could lead to upward pressure on margins, potentially reaching 30% over time [36][39] Question: Can you provide revenue details for Versus 12? - The expected revenue contribution from Versus 12 in Q4 is approximately $900,000, with a mix of subscription and consulting revenue [44][45] Question: What monetization strategies are being pursued for the career networks? - Management outlined several monetization strategies, including education offerings and job capabilities, with a focus on building value-added services for healthcare professionals [46][49] Question: Are there opportunities for brand marketing on the platform? - Management confirmed ambitions to model NurseGrid after platforms like LinkedIn and Doximity, recognizing the growing value of nurses in the healthcare industry [55][56] Question: What is the growth outlook for ShiftWizard in large organizations? - Management indicated that while ShiftWizard is not yet fully ready for the largest organizations, there is progress in securing contracts with upper middle-class enterprises [63]

Core Insights - OptimizeRx (OPRX) is transitioning towards AI-driven, workflow-integrated solutions, indicating a strategic evolution in digital pharma communications [1] - The company reported a year-over-year revenue growth of 11% to $21.9 million and a positive adjusted EBITDA of $1.5 million, showcasing a significant turnaround from the previous year's loss [1][11] Revenue and Growth Strategy - OPRX's investment in its Dynamic Audience Activation Platform (DAAP) and micro-targeting capabilities enhances patient and prescriber engagement [2] - The company is moving towards subscription-based data services, with over 5% of projected 2025 revenues secured in recurring contracts, which supports revenue predictability and higher margins [2] - OPRX has cut operating expenses by $5 million in 2024 and aims for a revenue guidance of $101-$106 million for the full year 2025, with adjusted EBITDA projected at $13-$15 million [3] Market Position and Competitive Landscape - OPRX is positioning itself as a platform rather than just a media vendor, aligning with the pharma industry's shift towards data-rich, cost-efficient digital strategies [5] - Peers like Doximity (DOCS) are also scaling AI investments, with significant growth in AI tool usage, indicating a competitive landscape focused on workflow integration [6][7] Financial Performance and Valuation - OPRX's shares have surged 173.3% year to date, outperforming the industry's growth of 17.8% [12] - The forward 12-month price-to-sales ratio for OPRX is 2.22X, lower than the industry average of 8.86X and its five-year median of 3.59X, indicating potential undervaluation [13] - The Zacks Consensus Estimate suggests a 63.6% improvement in OPRX's earnings per share for 2025 compared to 2024 [14]

Financial Overview - Full year revenues increased by 4.5%, net income rose by 31.5%, operating income grew by 32.9%, and adjusted EBITDA was up by 9% [7][39] - For Q4 2024, revenues were $74.2 million, up 5.2% from $70.6 million in Q4 2023, with subscription products accounting for 96% of total revenues [25][26] - Adjusted EBITDA for Q4 was $16.2 million, reflecting a 1.3% increase, with an adjusted EBITDA margin of 21.8% [30][39] Business Line Performance - Subscription revenue growth was driven by CredentialStream (28% growth), ShiftWizard (17% growth), and the Competency Suite (8% growth), while legacy products saw declines totaling approximately $1 million [27] - Professional Services revenues increased by 15.7% to $3.1 million [26] Market Data - Remaining performance obligations were $621 million, up from $541 million year-over-year, with expectations of approximately 40% conversion over the next 12 months [27] - The company maintains a strong cash balance of $97.2 million with no long-term debt, positioning it well for potential M&A opportunities [8][22] Company Strategy and Industry Competition - The company declared 2025 as the "Year of the Platform," focusing on enhancing interoperability among its applications and expanding its platform capabilities [11][13] - The HStream platform is expected to drive innovation and efficiency, allowing for faster development of new applications [13][14] Management Commentary on Operating Environment and Future Outlook - Management anticipates organic revenue growth between $302 million and $307 million for 2025, with net income expected between $19.2 million and $21.4 million [8][39] - The company is optimistic about its strong sales pipeline and expects to see growth concentrated in the second half of 2025 [79] Other Important Information - The board approved a dividend increase of 10.7% to $3.1 per share, reflecting confidence in the company's growth strategies [43] - The company has been recognized for its software applications, with the HealthStream Learning Center named the top software in healthcare by G2 [16][18] Q&A Session Summary Question: What will it take to achieve a 7% to 10% growth profile? - Management indicated that achieving this growth would require a combination of organic growth (5% to 7%) and inorganic growth (1% to 3%) through M&A [66][67] Question: Can you quantify the headwinds faced while shifting customers from Perpetual to SaaS? - Management suggested that the headwinds could be similar to the previous year, around 1% to 2% [74] Question: Are you seeing efficiencies from AI in product development? - Management confirmed that they are exploring AI applications internally to improve efficiency, though initial costs may rise before benefits are realized [84][86] Question: How successful have you been in incorporating pricing escalators into new contracts? - Management reported a success rate of over 95% in incorporating escalators into new contracts, which is expected to provide a new base level of growth [92][94] Question: When will the HealthStream Learning Experience (HLX) be fully launched? - The HLX is currently available for sale, with expectations for increased sales in the second half of the year following successful pilot programs [101]